A preliminary clinical study at Johns Hopkins Kimmel Cancer Center demonstrated that antibody treatment could decrease by half the number of cancer stem cells, which…
News
The diagnosis and management of myeloma in the very elderly is especially challenging, despite improvements in therapies. A review study, “Multiple myeloma in the very…
A research team led by William Matsui, MD, and Carol Ann Huff, MD, with the Johns Hopkins Kimmel Cancer Center, has found that MedImmune’s novel MEDI-551 antibody treatment…
Advocates working to raise awareness and funds for multiple myeloma successfully climbed Mount Kilimanjaro, and a documentary about the climb premiered last month at the Eden…
A screening study — the largest of its kind for myeloma — hopes to find a way to prevent myeloma before it develops. The study, called iStopMM…
Recent Posts
- FDA gives green light to first human trial testing cancer drug GTB-5550
- No one prepared me for the unwritten rules of caregiving
- Scientists test treatment strategy using ‘glioblastoma on a chip’
- Prostate cancer tool may cut risk for women in radiation therapy
- FDA OKs multiple myeloma combo for all newly diagnosed patients
